OTC
FDA Approves OTC Version of Opioid Overdose Reversal Agent
The FDA approved the OTC version of naloxone nasal spray to rapidly reverse the effects of opioid overdose.
MARCH 29, 2023
Sanofi and Roche Reach Tamiflu Deal
Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing, ...
JULY 24, 2019
Load more